TNFα potentiates IFNγ-induced cell death in oligodendrocyte progenitors

Journal of Neuroscience Research

Volumn 54, Issue 5, 1998, Pages 574-583

  Andrews, T ^a   Zhang, P ^a   Bhat, N R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cell death; Cytokines; Multiple sclerosis; Oligodendrocytes

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALPHA INTERFERON; CYSTEINE PROTEINASE; DNA FRAGMENT; ENZYME INHIBITOR; FAS ANTIGEN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE; NERVE PROTEIN; PEPTIDE CHLOROMETHYL KETONE; PROTEINASE INHIBITOR; RECOMBINANT GAMMA INTERFERON; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETICS; PHYSIOLOGY; RAT;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASES; CELLS, CULTURED; DRUG SYNERGISM; INTERFERON-GAMMA, RECOMBINANT; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PROTEASE INHIBITORS; RATS; RECOMBINANT PROTEINS; RNA, MESSENGER; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032217056     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19981201)54:5<574::AID-JNR2>3.0.CO;2-0     Document Type: Article

References (58)

1. Agresti C, D'Urso D, Levi G (1996): Reversible inhibitory effects of interferon-γ and tumor necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation. Eur J Neurosci 8:1106-1116.
2. Andrews T, Zhang P, Bhat NR (1996): Cytokines, ceramide and oligodendrocyte cytotoxicity. J Neurochem 66(Suppl 1):S89B.
3. Baerwald KD, Popko B (1998): Differentiating and mature oligodendrocytes respond differently to the immune cytokine interferon-γ. J Neurosci Res 52:230-239.
4. Baichwal VR, Baeuerle PA (1997): Apoptosis: Activate NF-κB or die? Curr Biol 7:R94-R96.
5. Becher B, Barker PA, Owens T, Antel JP (1998): CD95-CD95L: Can the brain learn from the immune system? Trends Neurosci 21:114-117.
6. Bhat NR, Zhang P (1996): Activation of MAP kinases in oligodendrocytes. J Neurochem 66:1986-1994.
7. Bhat NR, Hauser KF, Kindy MS (1992): Cell proliferation and protooncogene induction in oligodendroglial progenitors. J Neurosci Res 32:340-349.
8. Bhat NR, Zhang P, Lee JC, Hogan EL (1998): Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18:1633-1641.
9. Cheshire JL, Baldwin AS Jr (1997): Synergistic activation of NF-κB by tumor necrosis factor alpha and gamma interferon via enhanced IκBα degradation and de novo IκBβ degradation. Mol Cell Biol 17:6746-6754.
10. Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu X-Y (1997): Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 17:5328-5337.
11. Cohen GM (1997): Caspases: The executioners of apoptosis. Biochem J 326:1-16.
12. D'Souza S, Alinauskas K, McCrea E, Goodyer C, Antel JP (1995): Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci 15:7293-7300.
13. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP (1996): Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 184:2361-2370.
14. Delvenne P, Al-Saleh W, Gilles C, Thiry A, Boniver J (1995): Inhibition of growth of normal and human papilloma virus-transformed keratinocytes in monolayer and organotypic cultures by interferon-γ and tumor necrosis factor-α. Am J Pathol 146:589-598.
15. De Maria R, Testi R (1998): Fas-FasL interactions: A common pathogenetic mechanism in organ-specific autoimmunity. Immunol Today 19:121-125.
16. Dopp JM, Mackenziegraham A, Otero GC, Merrill JE (1997): Differential expression, cytokine modulation, and specific functions of Type-1 and Type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 75:104-112.
17. Dowling P, Bansil S, Menonna J, Cook S, Husar W (1996): Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 184:1513-1518.
18. Dowling P, Husar W, Menonna J, Donnenfeld H, Cook S, Sidhu M (1997): Cell death and birth in multiple sclerosis brain. J Neurol Sci 149:1-11.
19. Dubois-Dalq M, Armstrong R (1990): The cellular and molecular events of central nervous system remyelination. BioEssays 12:569-576.
20. Dugandžija-Novaković S, Shrager P (1995): Survival, development and electrical activity of central nervous system myelinated axons exposed to tumor necrosis factor in vitro. J Neurosci Res 40:117-126.
21. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992): Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
22. Hisahara S, Shoji S, Okano H, Miura M (1997): ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J Neurochem 69:10-20.
23. Horvitz HR, Shaham S, Hengartner MO (1994): The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harbor Symp Quant Biol 59:377-385.
24. Horwitz MS, Evans CF, McGavern DB, Rodriguez M, Oldstone MBA (1997): Primary demyelination in transgenic mice expressing interferon-γ. Nature Med 3:1037-1041.
25. Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR (1997): Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278:1630-1632.
26. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY, Goeddel DV (1991): Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88:2830-2834.
27. Louis J-C. Magel E, Takayama S, Varon S (1993): CNTF protection of oligodendrocytes of natural and tumor necrosis factor-induced death. Science 259:689-692.
28. Lucchinetti CF, Rodriguez M (1997): The controversy surrounding the pathogenesis of the multiple sclerosis lesion. Mayo Clin Proc 72:665-678.
29. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP (1998): Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nature Med 4:291-297.
30. McLarnon JG, Michikawa M, Kim SU (1993): Effects of tumor necrosis factor on inward potassium current and cell morphology in cultured human oligodendrocytes. Glia 9:120-126.
31. Merril JE (1991): Effects of interleukin-1 and tumor necrosis factor-α on astrocytes, microglia, oligodendrocytes and glial precursors in vitro. Dev Neurosci 13:130-137.
32. Montaldo PG, Carbone R, Corrias MV, Ferraris PC, Puzoni M (1994): Synergistic differentiation-promoting activity of interferon-γ and tumor necrosis factor-α: Role of receptor regulation on human neuroblasts. JNCI 86:1694-1701.
33. Mossman T (1983): Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 65:55-63.
34. Neish AS, Read MA, Thanos D, Pine R, Maniatis T, Collins T (1995): Endothelial interferon regulatory factor 1 cooperates with NF-κB as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 15:2558-2569.
35. Ozawa K, Suchanek G, Breitschopf H, Brück W, Budka H, Jellinger K, Lassman H (1994): Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117:1311-1322.
36. Popko B, Corbin JG, Baerwald KD, Dupree J, Garcia AM (1997): The effects of interferon-γ on the nervous system. Mol Neurobiol 14:19-35.
37. Prineas JW (1975): Pathology of the early lesion in multiple sclerosis. Hum Pathol 6:531-554.
38. Prineas JW (1985): The neuropathology of multiple sclerosis. In Vinken PJ, Bruyn GW, Klawans HL (eds): "Handbook of Clinical Neurology, Vol. 47." New York:Elsevier, pp 213-257.
39. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G (1995): Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α. Proc Natl Acad Sci USA 92:11294-11298.
40. Raine CS (1994): The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion. Ann Neurol 36:S61-S72.
41. Raine CS (1995): Multiple sclerosis: TNF revisited, with promise. Nature Med 1:211-214.
42. Schindler C (1998): STATs as activators of apoptosis. Trends Cell Biol 8:97-98.
43. Schindler C, Darnell JE (1995): Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Ann Rev Biochem 64:621-651.
44. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF (1991): Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J Immunol 147:1522-1529.
45. + current expression in cultured oligodendrocytes. J Memb Biol 124:127-137.
46. Steinman L (1993) Autoimmune disease. Sci Am 269:106-114.
47. Tamura T, Ueda S, Yoshida M, Matsuzaki M, Mohri H, Okubo T (1996): Interferon-γ induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemis cell line. Biochem Biophys Res Commun 229:21-26.
48. Tchélingérian J-L, Monge M, Le Saux F, Zalc B, Jacque C (1995): Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro. J Neurochem 65:2377-2380.
49. Torres C, Aranguez I, Rubio N (1995): Expression of interferon-γ receptors on murine oligodendrocytes and its regulation by cytokines and mitogens. Immunology 86:250-255.
50. Vartanian T, Li Y, Zhao M, Stefansson K (1995): interferon-γ-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol Med 1:732-743.
51. Vaux DL, Strasser A (1996): The molecular biology of apoptosis. Proc Natl Acad Sci USA 93:2239-2244.
52. Villa P, Kaufmann SH, Earnshaw WC (1997): Caspases and caspase inhibitors. Trends Biochem Sci 22:388-393.
53. Wang J, Nonomura N, Ichimaru N, Azuma H, Hatori M, Kokado Y, Matsimiya K, Miki T, Takahara S, Okuyama A (1997): Expression of Fas and Fas ligand in renal grafts with acute and chronic rejection in the rat model. J Interferon Cyt Res 17:369-373.
54. Wilt SG, Milward E, Zhou JM, Nagasato K, Patton H, Rusten R, Griffin DE, O'Conner M, Dubois-Dalq M (1995): In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 encephalopathy. Ann Neurol 37:381-394.
55. Yuan J (1997): Transducing signals of life and death. Curr Opin Cell Biol 9:247-251.
56. Zhang P, Miller BS, Rosenzweig SA, Bhat NR (1996): Activation of c-Jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. J Neurosci Res 46:114-121.
57. Zhang P, Andrews T, Bhat NR (1998a): TNFα potentiates IFNγ-induced oligodendrocyte cell death. J Neurochem 70:S9A.
58. Zhang P, Hogan EL, Bhat NR (1998b): Activation of JNK/SAPK in primary glial cultures: II. Differential activation of kinase isoforms corresponds to their differential expression. Neurochem Res 1998:219-225.